Acus vaistinė - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 2,323,036 | 2,526,199 | 2,227,236 | 2,293,483 | 2,826,457 | 3,682,597 | 4,203,920 | 4,389,710 |
| Profit before tax | 155,668 | 212,780 | 49,314 | 25,215 | 78,719 | 139,339 | 110,044 | 96,143 |
| Net profit | 132,318 | 183,819 | 39,584 | 21,318 | 66,929 | 118,596 | 93,593 | 80,497 |
| Equity | 755,486 | 955,096 | 994,605 | 945,335 | 1,000,499 | 1,072,036 | 1,148,570 | 1,229,067 |
| Liabilities | 10,361 | 60,760 | 73,624 | 51,146 | 10,061 | 147,261 | 1,636,762 | 1,159,062 |
| Non-current assets | 115,766 | 102,424 | 90,276 | 74,297 | 58,020 | 42,696 | 32,204 | 22,816 |
| Current assets | 944,720 | 913,432 | 977,953 | 886,084 | 952,540 | 1,176,601 | 1,446,008 | 1,451,380 |
| Total assets | 1,060,486 | 1,015,856 | 1,068,229 | 960,381 | 1,010,560 | 1,219,297 | 1,478,212 | 1,474,196 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 185,918 | 222,140 | 234,958 |
| Social insurance contributions | - | - | - | - | - | 115,181 | 139,829 | 145,941 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +1.9% | +8.7% | -11.8% | +3.0% | +23.2% | +30.3% | +14.2% | +4.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 12.5% | 18.1% | 3.7% | 2.2% | 6.6% | 9.7% | 6.3% | 5.5% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 17.5% | 19.2% | 4.0% | 2.3% | 6.7% | 11.1% | 8.1% | 6.5% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 5.7% | 7.3% | 1.8% | 0.9% | 2.4% | 3.2% | 2.2% | 1.8% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 6.7% | 8.4% | 2.2% | 1.1% | 2.8% | 3.8% | 2.6% | 2.2% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.0 | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | 1.4 | 0.9 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 163,979 | 166,562 | 134,306 | 138,301 | 164,648 | 215,567 | 214,669 | 254,476 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Acus vaistinė - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2022-10-28 | 2022-11-02 | 9.21 |
| 2022-08-23 | 2022-09-01 | 9.53 |
| 2022-07-25 | 2022-08-01 | 0.09 |
| 2022-07-18 | 2022-07-19 | 6104.21 |
| 2022-06-16 | 2022-06-20 | 50.31 |
| 2022-01-05 | 2022-01-10 | 1.70 |
| 2021-11-16 | 2021-11-18 | 15.85 |
Acus vaistinė - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-05-01 | 2025-05-01 | 10.44 |
| 2025-04-28 | 2025-04-28 | 9679.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Acus vaistine, UAB, code 166709042, is a Private Limited Liability Company engaged in retail sale of pharmaceutical products. In the latest financial year, 2025, the company generated revenue of €4.39M and net profit of €80.5K, corresponding to a profit margin of 1.8%. Revenue continued to grow year on year, rising 4.4% in 2025 and 19.2% over two years, from €3.68M in 2023 to €4.20M in 2024 and €4.39M in 2025. Profitability, however, weakened over the same period, with net profit falling from €118.6K in 2023 to €93.6K in 2024 and €80.5K in 2025. At the end of 2025, total assets stood at €1.47M, equity at €1.23M and liabilities at €1.16M. The equity ratio was 83.4%, debt-to-equity was 0.94, asset turnover reached 2.98x, ROE was 6.5% and ROA was 5.5%. Revenue per employee was €258.2K, while profit per employee was €4.7K.